MAPK pathway activity plays a key role in PD‐L1 expression of lung adenocarcinoma cells
Thijs S Stutvoet(University Medical Center Groningen), Steven de Jong(University Medical Center Groningen)
Cited by 163
Related Papers
Differential modulation of the TRAIL receptors and the CD95 receptor in colon carcinoma cell lines
|British Journal of Cancer|2003|62
Low-dose triple drug combination targeting the PI3K/AKT/mTOR pathway and the MAPK pathway is an effective approach in ovarian clear cell carcinoma
|Cancer Letters|2019|58
Molecular Imaging of PD-L1 Expression and Dynamics with the Adnectin-Based PET Tracer <sup>18</sup>F-BMS-986192
|Journal of Nuclear Medicine|2020|57
Integrative Kinome Profiling Identifies mTORC1/2 Inhibition as Treatment Strategy in Ovarian Clear Cell Carcinoma
|Clinical Cancer Research|2018|52